NIH-funded research U01 cooperative agreement

Continuous registry support for islet transplants to help people with brittle type 1 diabetes

Official title: Continuation of The Collaborative Islet Transplantation Registry (CITR)

Funded at The Emmes Company, LLC · NIH-11365197 · Data updated 2026-11-12

A national registry study will track how well islet transplantation and related therapies work and stay safe in people with brittle diabetes due to type 1 diabetes.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionThe Emmes Company, LLC
NIH-funded
Lab location1 site (Rockville, United States)
Project startSeptember 15, 2022
Project endJune 30, 2027
Funding year2026
Award (this year)$633,968
NIH project number5U01DK133709-05
Project IDNIH-11365197 on NIH RePORTER

Who could benefit from this research

Could help

Adults with brittle type 1 diabetes who have undergone allogeneic or autologous islet transplantation or are candidates for beta cell replacement therapies.

Less likely to help

Non-diabetic individuals or patients not considering islet transplantation or beta cell replacement would not directly benefit.

What this research studies

This project maintains and analyzes a large registry of both donor-derived (allogeneic) and patient-derived (autologous) islet transplants and other beta cell replacement therapies. Researchers will collect and harmonize data on transplant outcomes, safety, and long-term effectiveness to understand who benefits most and under what conditions. The work is performed by a Data and Statistical Coordinating Center to support the CITR investigators and ensure high-quality, comparable information across sites. The registry helps clinicians and patients make informed decisions about using islet transplantation to reduce severe glycemic episodes and improve glucose control. Participation involves data contributed from transplant centers and patient records, with attention to privacy and safety.

Why it matters

Potential benefit: If successful, the registry could improve knowledge about who benefits from islet transplantation and guide better patient selection and post-transplant care.

How similar studies have gone: Registry-based efforts in transplant medicine have improved understanding of long-term outcomes and safety in multiple settings, though CITR-specific results remain essential.

Where this research is happening

  • The Emmes Company, LLC
    Rockville, United States
    Active

Researchers

  • Principal investigator: Payne, Elizabeth Holly — The Emmes Company, LLC
  • Study coordinator: Payne, Elizabeth Holly

Related research

Other NIH-funded projects on the same topics.

  • How air pollution during pregnancy affects fetal growth over time

    This study looks at how air pollution affects the growth of babies in the womb during pregnancy, using ultrasound images to track changes over time, and it aims to help expectant parents understand when their babies might be most at risk from pollution.

    NIH research The Emmes Company, LLC · Rockville, United States · NIH-9986964

  • Coordinating center for clinical trials on monkeypox

    This study is all about making clinical trials for monkeypox better by using online tools to collect and manage data, so that patients can get improved treatments and a clearer understanding of the condition.

    NIH research The Emmes Company, LLC · Rockville, United States · NIH-11294130

  • Improving clinical trials for influenza through data coordination and analysis

    This study is working to make flu clinical trials better and more accurate, so that patients like you can benefit from improved treatments for the flu.

    NIH research The Emmes Company, LLC · Rockville, United States · NIH-11294127

  • Investigating ways to combat antibacterial resistance through data coordination and analysis.

    This study is all about helping researchers find better ways to fight antibiotic resistance by using smart online tools to collect and manage data, and they’re here to support other scientists in designing their trials to make sure they get the best results.

    NIH research The Emmes Company, LLC · Rockville, United States · NIH-11294126

  • A center for managing and analyzing data in infectious disease clinical trials

    This study is all about helping researchers run better clinical trials for infectious diseases by using online tools to collect data and making sure everything is accurate, so they can get trustworthy results that can help patients like you.

    NIH research The Emmes Company, LLC · Rockville, United States · NIH-11294125

  • Improving treatment for opioid addiction and misuse

    This study is looking for better ways to help people dealing with opioid addiction by testing new treatments and strategies, so if you're struggling with this issue, you might have a chance to participate in trials that could lead to improved recovery options.

    NIH research The Emmes Company, LLC · Rockville, United States · NIH-11220985

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.